Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies.

Oudeman J, Eftimov F, Strijkers GJ, Schneiders JJ, Roosendaal SD, Engbersen MP, Froeling M, Goedee HS, van Doorn PA, Caan MWA, van Schaik IN, Maas M, Nederveen AJ, de Visser M, Verhamme C.

Neurology. 2020 Jan 7;94(1):e62-e74. doi: 10.1212/WNL.0000000000008697. Epub 2019 Dec 11.

PMID:
31827006
2.

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study.

Adrichem ME, Bus SR, Wieske L, Mohammed H, Verhamme C, Hadden R, van Schaik IN, Eftimov F.

Eur J Neurol. 2020 Mar;27(3):506-513. doi: 10.1111/ene.14096. Epub 2019 Nov 7.

3.

Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.

Lucke IM, Wieske L, van der Kooi AJ, van Schaik IN, Eftimov F, Verhamme C.

J Peripher Nerv Syst. 2019 Jun;24(2):174-179. doi: 10.1111/jns.12325. Epub 2019 May 29.

PMID:
31090121
4.

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy.

van Lieverloo GGA, Wieske L, Verhamme C, Vrancken AFJ, van Doorn PA, Michalak Z, Barro C, van Schaik IN, Kuhle J, Eftimov F.

J Peripher Nerv Syst. 2019 Jun;24(2):187-194. doi: 10.1111/jns.12319. Epub 2019 Apr 29.

PMID:
30973667
5.

Modifier Gene Candidates in Charcot-Marie-Tooth Disease Type 1A: A Case-Only Genome-Wide Association Study.

Tao F, Beecham GW, Rebelo AP, Blanton SH, Moran JJ, Lopez-Anido C, Svaren J, Abreu L, Rizzo D, Kirk CA, Wu X, Feely S, Verhamme C, Saporta MA, Herrmann DN, Day JW, Sumner CJ, Lloyd TE, Li J, Yum SW, Taroni F, Baas F, Choi BO, Pareyson D, Scherer SS, Reilly MM, Shy ME, Züchner S; Inherited Neuropathy Consortium.

J Neuromuscul Dis. 2019;6(2):201-211. doi: 10.3233/JND-190377.

6.

Muscle weakness in a S. pneumoniae sepsis mouse model.

Witteveen E, Wieske L, Manders E, Verhamme C, Ottenheijm CAC, Schultz MJ, van Schaik IN, Horn J.

Ann Transl Med. 2019 Jan;7(1):9. doi: 10.21037/atm.2018.12.45.

7.

Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Tao F, Beecham GW, Rebelo AP, Svaren J, Blanton SH, Moran JJ, Lopez-Anido C, Morrow JM, Abreu L, Rizzo D, Kirk CA, Wu X, Feely S, Verhamme C, Saporta MA, Herrmann DN, Day JW, Sumner CJ, Lloyd TE, Li J, Yum SW, Taroni F, Baas F, Choi BO, Pareyson D, Scherer SS, Reilly MM, Shy ME, Züchner S; Inherited Neuropathy Consortium.

Ann Neurol. 2019 Mar;85(3):316-330. doi: 10.1002/ana.25426.

PMID:
30706531
8.

Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.

Lucke IM, Adrichem ME, Wieske L, van der Kooi AJ, Verhamme C, van Schaik IN, Eftimov F.

J Neurol Sci. 2019 Feb 15;397:141-145. doi: 10.1016/j.jns.2018.12.036. Epub 2018 Dec 31.

PMID:
30623818
9.

Nerve ultrasound: A reproducible diagnostic tool in peripheral neuropathy.

Telleman JA, Herraets IJT, Goedee HS, Verhamme C, Nikolakopoulos S, van Asseldonk JH, van der Pol WL, van den Berg LH, Visser LH.

Neurology. 2018 Dec 28. pii: 10.1212/WNL.0000000000006856. doi: 10.1212/WNL.0000000000006856. [Epub ahead of print]

PMID:
30593519
10.

Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.

Weterman MAJ, Kuo M, Kenter SB, Gordillo S, Karjosukarso DW, Takase R, Bronk M, Oprescu S, van Ruissen F, Witteveen RJW, Bienfait HME, Breuning M, Verhamme C, Hou YM, de Visser M, Antonellis A, Baas F.

Hum Mol Genet. 2018 Dec 1;27(23):4036-4050. doi: 10.1093/hmg/ddy290.

11.

Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.

van Lieverloo GGA, Peric S, Doneddu PE, Gallia F, Nikolic A, Wieske L, Verhamme C, van Schaik IN, Nobile-Orazio E, Basta I, Eftimov F.

J Neurol. 2018 Sep;265(9):2052-2059. doi: 10.1007/s00415-018-8948-y. Epub 2018 Jul 2.

12.

No association between systemic complement activation and intensive care unit-acquired weakness.

Witteveen E, Wieske L, de Beer FM, Juffermans NP, Verhamme C, Schultz MJ, van Schaik IN, Horn J; BASIC study group.

Ann Transl Med. 2018 Apr;6(7):115. doi: 10.21037/atm.2018.01.30.

13.

Diffusion tensor MRI of the healthy brachial plexus.

Oudeman J, Verhamme C, Engbersen MP, Caan MWA, Maas M, Froeling M, Nederveen AJ, Strijkers GJ.

PLoS One. 2018 May 9;13(5):e0196975. doi: 10.1371/journal.pone.0196975. eCollection 2018.

14.

Early Prediction of Intensive Care Unit-Acquired Weakness: A Multicenter External Validation Study.

Witteveen E, Wieske L, Sommers J, Spijkstra JJ, de Waard MC, Endeman H, Rijkenberg S, de Ruijter W, Sleeswijk M, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

J Intensive Care Med. 2018 Jan 1:885066618771001. doi: 10.1177/0885066618771001. [Epub ahead of print]

PMID:
29716425
15.

Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy.

Lucke IM, Peric S, van Lieverloo GGA, Wieske L, Verhamme C, van Schaik IN, Basta I, Eftimov F.

J Peripher Nerv Syst. 2018 Mar;23(1):49-54. doi: 10.1111/jns.12250. Epub 2018 Feb 6.

PMID:
29341326
16.

Pharmacodynamics and Pharmacokinetics of Lidocaine in a Rodent Model of Diabetic Neuropathy.

Ten Hoope W, Hollmann MW, de Bruin K, Verberne HJ, Verkerk AO, Tan HL, Verhamme C, Horn J, Rigaud M, Picardi S, Lirk P.

Anesthesiology. 2018 Mar;128(3):609-619. doi: 10.1097/ALN.0000000000002035.

PMID:
29251644
17.

Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations.

van Paassen BW, Bronk M, Verhamme C, van Ruissen F, Baas F, van Spaendonck-Zwarts KY, de Visser M.

J Peripher Nerv Syst. 2017 Dec;22(4):464-467. doi: 10.1111/jns.12236. Epub 2017 Sep 11.

PMID:
28837237
18.

Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study.

Witteveen E, Sommers J, Wieske L, Doorduin J, van Alfen N, Schultz MJ, van Schaik IN, Horn J, Verhamme C.

Ann Intensive Care. 2017 Dec;7(1):40. doi: 10.1186/s13613-017-0263-8. Epub 2017 Apr 5.

19.

Increased Early Systemic Inflammation in ICU-Acquired Weakness; A Prospective Observational Cohort Study.

Witteveen E, Wieske L, van der Poll T, van der Schaaf M, van Schaik IN, Schultz MJ, Verhamme C, Horn J; Molecular Diagnosis and Risk Stratification of Sepsis (MARS) Consortium.

Crit Care Med. 2017 Jun;45(6):972-979. doi: 10.1097/CCM.0000000000002408.

PMID:
28350642
20.

Muscle imaging in inherited and acquired muscle diseases.

Ten Dam L, van der Kooi AJ, Verhamme C, Wattjes MP, de Visser M.

Eur J Neurol. 2016 Apr;23(4):688-703. doi: 10.1111/ene.12984. Review.

PMID:
27000978
21.

In Patients with an α-Galactosidase A Variant, Small Nerve Fibre Assessment Cannot Confirm a Diagnosis of Fabry Disease.

van der Tol L, Verhamme C, van Schaik IN, van der Kooi AJ, Hollak CE, Biegstraaten M.

JIMD Rep. 2016;28:95-103. Epub 2015 Nov 14.

22.

Diffusion-prepared neurography of the brachial plexus with a large field-of-view at 3T.

Oudeman J, Coolen BF, Mazzoli V, Maas M, Verhamme C, Brink WM, Webb AG, Strijkers GJ, Nederveen AJ.

J Magn Reson Imaging. 2016 Mar;43(3):644-54. doi: 10.1002/jmri.25025. Epub 2015 Aug 6.

PMID:
26251015
23.

Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model.

Witteveen E, Hoogland IC, Wieske L, Weber NC, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

Muscle Nerve. 2016 Jan;53(1):127-33. doi: 10.1002/mus.24711. Epub 2015 Nov 21.

24.

Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study.

Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, Nollet F, van Schaik IN, Schultz MJ, Horn J, van der Schaaf M.

Crit Care. 2015 Apr 27;19:196. doi: 10.1186/s13054-015-0937-2.

25.

The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.

Han C, Yang Y, de Greef BT, Hoeijmakers JG, Gerrits MM, Verhamme C, Qu J, Lauria G, Merkies IS, Faber CG, Dib-Hajj SD, Waxman SG.

Neuromolecular Med. 2015 Jun;17(2):158-69. doi: 10.1007/s12017-015-8347-9. Epub 2015 Mar 20.

PMID:
25791876
26.

Is gentamicin affecting the neuromuscular system of critically ill patients?

Wieske L, van Hest RM, Witteveen E, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

Intensive Care Med. 2015 Apr;41(4):727-8. doi: 10.1007/s00134-015-3731-3. Epub 2015 Mar 10. No abstract available.

PMID:
25752304
27.

Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study.

Wieske L, Verhamme C, Witteveen E, Bouwes A, Dettling-Ihnenfeldt DS, van der Schaaf M, Schultz MJ, van Schaik IN, Horn J.

Neurocrit Care. 2015 Jun;22(3):385-94. doi: 10.1007/s12028-014-0066-9.

PMID:
25403763
28.

Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study.

Wieske L, Witteveen E, Verhamme C, Dettling-Ihnenfeldt DS, van der Schaaf M, Schultz MJ, van Schaik IN, Horn J.

PLoS One. 2014 Oct 27;9(10):e111259. doi: 10.1371/journal.pone.0111259. eCollection 2014.

29.

Reply: Age-dependent penetrance among females with X-linked adrenoleukodystrophy.

Engelen M, Barbier M, Dijkstra IM, Schür R, de Bie RM, Verhamme C, Dijkgraaf MG, Aubourg PA, Wanders RJ, van Geel BM, de Visser M, Poll-The BT, Kemp S.

Brain. 2015 Feb;138(Pt 2):e326. doi: 10.1093/brain/awu233. Epub 2014 Aug 22. No abstract available.

PMID:
25149411
30.

Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in Zucker diabetic fatty rats.

Lirk P, Verhamme C, Boeckh R, Stevens MF, ten Hoope W, Gerner P, Blumenthal S, de Girolami U, van Schaik IN, Hollmann MW, Picardi S.

Br J Anaesth. 2015 Feb;114(2):319-26. doi: 10.1093/bja/aeu270. Epub 2014 Aug 21.

31.

Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review.

Witteveen E, Wieske L, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

J Neurol Sci. 2014 Oct 15;345(1-2):15-25. doi: 10.1016/j.jns.2014.07.014. Epub 2014 Jul 16. Review.

PMID:
25128472
32.

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern.

Eftimov F, Liesdek MH, Verhamme C, van Schaik IN; PREDICT study group.

BMC Neurol. 2014 Apr 4;14:72. doi: 10.1186/1471-2377-14-72.

33.

PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.

van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M.

Orphanet J Rare Dis. 2014 Mar 19;9:38. doi: 10.1186/1750-1172-9-38. Review.

34.

X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.

Engelen M, Barbier M, Dijkstra IM, Schür R, de Bie RM, Verhamme C, Dijkgraaf MG, Aubourg PA, Wanders RJ, van Geel BM, de Visser M, Poll-The BT, Kemp S.

Brain. 2014 Mar;137(Pt 3):693-706. doi: 10.1093/brain/awt361. Epub 2014 Jan 29.

PMID:
24480483
35.

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study.

Wieske L, Witteveen E, Petzold A, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

Crit Care. 2014 Jan 20;18(1):R18. doi: 10.1186/cc13699.

36.

Autonomic dysfunction in ICU-acquired weakness: a prospective observational pilot study.

Wieske L, Chan Pin Yin DR, Verhamme C, Schultz MJ, van Schaik IN, Horn J.

Intensive Care Med. 2013 Sep;39(9):1610-7. doi: 10.1007/s00134-013-2991-z. Epub 2013 Jun 21.

PMID:
23793889
37.

Examination of cardiovascular and peripheral autonomic function in the ICU: a pilot study.

Wieske L, Kiszer ER, Schultz MJ, Verhamme C, van Schaik IN, Horn J.

J Neurol. 2013 Jun;260(6):1511-7. doi: 10.1007/s00415-012-6818-6. Epub 2012 Dec 30.

PMID:
23275003
38.

The phenotype of the Gly94fsX222 PMP22 insertion.

de Vries SD, Verhamme C, van Ruissen F, van Paassen BW, Arts WF, Kerkhoff H, van Engelen BG, Lammens M, de Visser M, Baas F, van der Kooi AJ.

J Peripher Nerv Syst. 2011 Jun;16(2):113-8. doi: 10.1111/j.1529-8027.2011.00333.x.

PMID:
21692910
39.

Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.

Verhamme C, King RH, ten Asbroek AL, Muddle JR, Nourallah M, Wolterman R, Baas F, van Schaik IN.

J Neuropathol Exp Neurol. 2011 May;70(5):386-98. doi: 10.1097/NEN.0b013e318217eba0.

PMID:
21487305
40.

Ascorbic acid for treatment in CMT1A: what's next?

de Visser M, Verhamme C.

Lancet Neurol. 2011 Apr;10(4):291-3. doi: 10.1016/S1474-4422(11)70042-4. No abstract available.

PMID:
21393064
41.

Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.

Videler AJ, Beelen A, van Schaik IN, Verhamme C, van den Berg LH, de Visser M, Nollet F.

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):828-33. doi: 10.1136/jnnp.2009.187302. Epub 2010 Jun 18.

PMID:
20562406
42.

Age-related changes in motor unit number estimates in adult patients with Charcot-Marie-Tooth type 1A.

van Dijk JP, Verhamme C, van Schaik IN, Schelhaas HJ, Mans E, Bour LJ, Stegeman DF, Zwarts MJ.

Eur J Neurol. 2010 Aug;17(8):1098-104. doi: 10.1111/j.1468-1331.2010.03027.x. Epub 2010 Apr 27.

PMID:
20443982
43.

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial.

Verhamme C, de Haan RJ, Vermeulen M, Baas F, de Visser M, van Schaik IN.

BMC Med. 2009 Nov 12;7:70. doi: 10.1186/1741-7015-7-70.

44.

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.

Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M.

Brain. 2009 Dec;132(Pt 12):3252-62. doi: 10.1093/brain/awp251.

PMID:
19843647
45.

Comparison of CMT1A and CMT2: similarities and differences.

Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M.

J Neurol. 2006 Dec;253(12):1572-80. Epub 2006 Aug 28.

PMID:
16941080
46.

[From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies].

Verhamme C, Baas F.

Ned Tijdschr Geneeskd. 2005 Jul 2;149(27):1505-9. Review. Dutch.

PMID:
16032995
47.

Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model.

ten Asbroek AL, Verhamme C, van Groenigen M, Wolterman R, de Kok-Nazaruk MM, Baas F.

J Neurosci Res. 2005 Mar 15;79(6):825-35.

PMID:
15672449
48.

Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia.

Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, Vermeulen M, de Visser M.

J Neurol. 2004 Dec;251(12):1491-7.

PMID:
15645349
49.

Development of rat blastocysts under the kidney capsule of nude mice. Prolonged survival and absence of immunization.

Zeilmaker GH, Verhamme CM.

Transplantation. 1979 Mar;27(3):214-6. No abstract available.

PMID:
432939
50.

A simplified method for freezing mouse embryos.

Zeilmaker GH, Verhamme CM.

Cryobiology. 1979 Feb;16(1):6-10. No abstract available.

PMID:
436438

Supplemental Content

Loading ...
Support Center